Characterization of a Soluble Ligand Binding Domain of the NMDA Receptor Regulatory Subunit NR3A
Open Access
- 26 April 2006
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 26 (17), 4559-4566
- https://doi.org/10.1523/jneurosci.0560-06.2006
Abstract
NR3A is expressed widely in the developing CNS of mammals. Coassembly of NR3A with NR1 and NR2 modifies NMDA receptor-mediated responses, reducing calcium permeability and single-channel conductance. The ligand binding properties of NR3A are unknown but shape the role NR3A plays when incorporated into NMDA receptors. Here, a soluble NR3A ligand binding domain (NR3A S1S2) was constructed based on amino acid sequence alignments with other glutamate receptor ion channels and is expressed inEscherichia coli. After purification by affinity, gel filtration, and ion exchange chromatography, NR3A S1S2 behaves as a monomer even at a concentration of 20 mg/ml, as determined by size-exclusion chromatography and dynamic light scattering. NR3A S1S2 has very high affinity for glycine with an apparent dissociation constant (Kd) of 40 nm, 650-fold less than theKdfor NR1. Glutamate, which binds to NR2 subunits, also binds to NR3A, but with very low affinity (Kd= 9.6 mm); in contrast, binding of glutamate to NR1 was not detectable even at a 300 mmconcentration. The antagonist binding profiles of NR3A and NR1 also show striking differences. 6-Cyano-2,3-dihydroxy-7-nitro-quinoxaline (CNQX), and its analogCGP78608, bind to NR3A S1S2 with low micromolar affinity, whereas for NR1, the affinity ofCGP78608increases 1000-fold compared with CNQX. Other high-affinity NR1 antagonists also show very weak binding to NR3A. Proteolysis protection experiments reveal that CNQX andCGP78608bind to and stabilize domain 1 of NR3A S1S2 but increase proteolysis of domain 2, indicating that they produce conformational changes distinct from those induced by glycine andd-serine.Keywords
This publication has 29 references indexed in Scilit:
- Relating NMDA Receptor Function to Receptor Subunit Composition: Limitations of the Pharmacological ApproachJournal of Neuroscience, 2006
- D-Serine Is the Dominant Endogenous Coagonist for NMDA Receptor Neurotoxicity in Organotypic Hippocampal SlicesJournal of Neuroscience, 2005
- Mechanism of Partial Agonist Action at the NR1 Subunit of NMDA ReceptorsNeuron, 2005
- Crystal Structures of the GluR5 and GluR6 Ligand Binding Cores: Molecular Mechanisms Underlying Kainate Receptor SelectivityNeuron, 2005
- Crystal structure of the kainate receptor GluR5 ligand‐binding core in complex with (S)‐glutamateFEBS Letters, 2005
- Mechanisms for Activation and Antagonism of an AMPA-Sensitive Glutamate Receptor: Crystal Structures of the GluR2 Ligand Binding CoreNeuron, 2000
- Probing the ligand binding domain of the GluR2 receptor by proteolysis and deletion mutagenesis defines domain boundaries and yields a crystallizable constructProtein Science, 1998
- Memories of NMDA receptors and LTPTrends in Neurosciences, 1995
- Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit compositionEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Molecular Diversity of Glutamate Receptors and Implications for Brain FunctionScience, 1992